Yuranga Weerakkody on Radiopaedia.org

Yuranga Weerakkody

MBChB FRANZCR

Dr Yuranga Weerakkody is a consultant radiologist with subspecialist expertise and interests primarily in thoracic imaging and some aspects of cardiovascular, oncology and prostate imaging.

During early stages of radiopaedia, he framed the foundations of most of current thoracic imaging and obstetrics and gynaecology article content within this site. He has been part of the editorial board for over 15 years and served as managing editor (international) of radiopaedia for 9 years from 2011 to 2020.

He is an associate editor for the Journal of Medical Imaging and Radiation Oncology (JMIRO) and sits on several medical imaging related educational, advisory and governance panels. 

He has been a moderator and RANZCR phase-2 examiner for thoracic imaging components and convened parts of the RANZCR Western Australian Radiology State Training program and radiology components of the undergraduate medical training program of the University of Western Australia. 

Disclosures:
  • Nothing to disclose
37 results found
Yuranga Weerakkody edited the...
Article ROS1 mutation 7 months ago
Reviewed by Rohit Sharma 7 months ago
Yuranga Weerakkody edited the...
Article Atypical pulmonary carcinoid tumor over 1 year ago
Reviewed by Yahya Baba over 1 year ago
Yuranga Weerakkody created the...
Article Peribronchiolar metaplasia over 1 year ago
Reviewed by Henry Knipe over 1 year ago
Yuranga Weerakkody edited the...
Article Klebsiella almost 2 years ago
Reviewed by Sonam Vadera almost 2 years ago
Yuranga Weerakkody edited the...
Article Tumor spread through air spaces almost 2 years ago
Reviewed by Yahya Baba almost 2 years ago
Yuranga Weerakkody edited the...
Article Fistula about 2 years ago
Reviewed by Edgar Lorente about 2 years ago
Yuranga Weerakkody edited the...
Article Anaplastic lymphoma kinase (ALK) gene rearrangements over 2 years ago
Reviewed by Joachim Feger over 2 years ago
Yuranga Weerakkody edited the...
Article EGFR mutation about 3 years ago
Reviewed by Yahya Baba about 3 years ago
Yuranga Weerakkody created the...
Article Neuron specific enolase over 3 years ago
Reviewed by Edgar Lorente over 3 years ago
Yuranga Weerakkody edited the...
Article Programmed death-ligand 1 (PD-L1)-targeted monoclonal antibodies about 4 years ago
Reviewed by Owen Kang about 4 years ago
Yuranga Weerakkody edited the...
Article Human coronavirus about 4 years ago
Reviewed by Rohit Sharma about 4 years ago
Yuranga Weerakkody edited the...
Article Anaplastic lymphoma kinase (ALK) gene rearrangements over 4 years ago
Reviewed by Francesco Sciacca over 4 years ago
Yuranga Weerakkody edited the...
Article Well differentiated fetal adenocarcinoma of lung over 4 years ago
Reviewed by Rohit Sharma over 4 years ago
Yuranga Weerakkody created the...
Article Primary pulmonary enteric adenocarcinoma almost 5 years ago
Reviewed by Ian Bickle almost 5 years ago
Yuranga Weerakkody edited the...
Article KRAS mutation almost 5 years ago
Reviewed by Ian Bickle almost 5 years ago
Yuranga Weerakkody edited the...
Article EGFR mutation almost 5 years ago
Reviewed by Ian Bickle almost 5 years ago
Yuranga Weerakkody edited the...
Article Anaplastic lymphoma kinase (ALK) gene rearrangements almost 5 years ago
Reviewed by Ian Bickle almost 5 years ago
Yuranga Weerakkody created the...
Article ROS1 mutation almost 5 years ago
Reviewed by Daniel J Bell almost 5 years ago
Yuranga Weerakkody edited the...
Article EGFR mutation almost 5 years ago
Reviewed by Ayla Al Kabbani almost 5 years ago
Yuranga Weerakkody created the...
Article Well differentiated fetal adenocarcinoma of lung almost 5 years ago
Reviewed by Ayla Al Kabbani almost 5 years ago
Yuranga Weerakkody edited the...
Article Programmed death-ligand 1 (PD-L1)-targeted monoclonal antibodies almost 5 years ago
Reviewed by Ayla Al Kabbani almost 5 years ago
Yuranga Weerakkody created the...
Article Atypical pulmonary carcinoid tumor almost 5 years ago
Reviewed by Ayla Al Kabbani almost 5 years ago
Yuranga Weerakkody edited the...
Article EGFR mutation almost 5 years ago
Reviewed by Andrew Murphy almost 5 years ago
Yuranga Weerakkody edited the...
Article KRAS mutation almost 5 years ago
Reviewed by Francis Deng almost 5 years ago
Yuranga Weerakkody created the...
Article Vascular invasion in lung cancer almost 5 years ago
Reviewed by Ayla Al Kabbani almost 5 years ago
Yuranga Weerakkody created the...
Article Tumor spread through air spaces almost 5 years ago
Reviewed by Bruno Di Muzio almost 5 years ago
Yuranga Weerakkody edited the...
Article EGFR mutation almost 5 years ago
Reviewed by Ayla Al Kabbani almost 5 years ago
Yuranga Weerakkody created the...
Article HER-2 mutations in lung cancer almost 5 years ago
Reviewed by Ian Bickle almost 5 years ago
Yuranga Weerakkody created the...
Article KRAS mutation almost 5 years ago
Reviewed by Daniel J Bell almost 5 years ago
Yuranga Weerakkody created the...
Article EGFR mutation almost 5 years ago
Reviewed by Bruno Di Muzio almost 5 years ago
Yuranga Weerakkody created the...
Article Anaplastic lymphoma kinase (ALK) gene rearrangements almost 5 years ago
Reviewed by Bruno Di Muzio almost 5 years ago
Yuranga Weerakkody created the...
Article Thyroid transcription factor 1 almost 5 years ago
Reviewed by Ayla Al Kabbani almost 5 years ago
Yuranga Weerakkody created the...
Article Programmed death-ligand 1 (PD-L1)-targeted monoclonal antibodies almost 5 years ago
Reviewed by Vincent Tatco almost 5 years ago
Yuranga Weerakkody edited the...
Article Primary lung tumors in children over 5 years ago
Reviewed by Ian Bickle over 5 years ago
Yuranga Weerakkody created the...
Article Pulmonary Acinetobacter infection over 5 years ago
Reviewed by Jeffrey Cheng over 5 years ago
Yuranga Weerakkody created the...
Article Liquefactive necrosis almost 7 years ago
Reviewed by Frank Gaillard almost 7 years ago
Yuranga Weerakkody edited the...
Article Mycobacterium tuberculosis over 10 years ago
Reviewed by Yuranga Weerakkody over 10 years ago

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.